Related Experiment Video
Updated: May 5, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Heart Failure in Type 1 vs. Type 2 Diabetes Mellitus: Shared Pathways, Distinct Challenges
Muhammad S Hussain1, Saraswathi Iyer1, Yi Jia Liew1
1Division of Cardiovascular Research, University of Dundee, Dundee, Scotland, UK, dundee.ac.uk.
Insights
Heart failure (HF) is a serious complication for people with type 1 (T1D) and type 2 diabetes (T2D). This review highlights key differences in HF epidemiology, pathophysiology, and outcomes between T1D and T2D.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Heart failure (HF) is a critical complication in both type 1 diabetes (T1D) and type 2 diabetes (T2D).
- Individuals with diabetes exhibit a higher risk of developing HF compared to the general population.
- Diabetic cardiomyopathy, characterized by insulin deficiency, insulin resistance, inflammation, and myocardial fibrosis, underlies HF in diabetes.
Purpose of the Study:
- To review the burden, pathophysiology, and outcomes of HF in patients with diabetes.
- To emphasize the distinct differences in HF between T1D and T2D.
- To identify the unmet needs in managing T1D patients with HF.
Main Methods:
- Literature review of existing studies on HF in diabetes.
- Comparative analysis of epidemiological data, pathophysiological mechanisms, treatment strategies, and clinical outcomes.
- Focus on differentiating HF characteristics in T1D versus T2D.
Main Results:
- Similarities and key differences in HF epidemiology and pathophysiology exist between T1D and T2D.
- Treatment approaches and clinical outcomes for HF also vary between T1D and T2D.
- A significant unmet need exists for T1D patients experiencing HF.
Conclusions:
- Understanding the specific nuances of HF in T1D and T2D is crucial for effective management.
- Further research and targeted therapies are required, particularly for T1D patients with HF.
- Addressing the unmet needs in T1D-associated HF is a priority for improving patient outcomes.
Abstract:
Heart failure (HF) is a critical complication in both type 1 (T1D) and type 2 diabetes (T2D) and people with diabetes are at higher risk of developing HF than those without diabetes. The pathophysiology of HF in diabetes often involves diabetic cardiomyopathy, driven by insulin deficiency, insulin resistance (IR), inflammation, and myocardial fibrosis; however, though there are similarities in HF in T1D and T2D, there are also key differences in epidemiology, pathophysiology, treatment, and clinical outcomes. In this review article we will discuss the burden, pathophysiology, and outcomes of HF in diabetes, focusing on differences between T1D and T2D, and the relative unmet need for patients with T1D and HF.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Heart Failure II: Pathophysiology
Type II Diabetes I: Introduction
Pathophysiology of Heart Failure
Heart Failure I: Introduction

